{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:17:05Z","timestamp":1773339425112,"version":"3.50.1"},"reference-count":15,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>The NB.1.8.1 Omicron subvariant has demonstrated notable epidemiological relevance in India, though without evidence of a marked increase in severity compared to prior Omicron waves. Understanding its genomic trajectory and policy implications is critical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective convergent mixed-methods study integrating genomic sequencing (GISAID, INSACOG), epidemiological counts (ICMR, WHO, CDC), and policy\/advisory analysis (MoHFW, WHO-SEARO). Data were analysed across January\u2013May 2025 using prevalence tracking, hospitalisation comparisons, and thematic policy review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Genomic analyses showed NB.1.8.1 carrying lineage-defining spike mutations (A435S, V445H, T478I) linked to transmissibility and immune escape. While prevalence rose in China, India reported &lt;5% share. Hospitalisation burdens remained lower in India than in China. India\u2019s policy response showed increasing alignment between genomic surveillance outputs and subsequent public health advisories, with targeted booster promotion and enhanced surveillance in high-incidence States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and conclusions<\/jats:title>\n                    <jats:p>NB.1.8.1 illustrates the dynamic evolutionary trajectory of SARS-CoV-2. India\u2019s adaptive genomic surveillance and flexible public health frameworks contributed to mitigating clinical severity, though surveillance gaps and rural under-reporting remain concerns. Sustained genomic tracking, booster equity, and real-time advisory mechanisms are needed to strengthen preparedness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijmr_1558_2025","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T16:26:13Z","timestamp":1772382373000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emergence of SARS-CoV-2 omicron subvariant NB.1.8.1 in India: Genomic evolution, transmission patterns, and public health implications"],"prefix":"10.25259","volume":"163","author":[{"given":"Shikha","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Operations and HIPAA Compliance, Lab Testing API Inc., Wilmington, United States"},{"name":"Centre for Distance and Online Education, Panjab University, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanth Kumar","family":"Manikyam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Chalapathi Institute of Pharmaceutical Sciences, Chalapathi Nagar Guntur- affiliated to Acharya Nagarjuna University, Guntur, Andhra Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"10.25259\/IJMR_1558_2025\/ref-1","volume-title":"Tracking SARS-CoV-2 variants","author":"World Health Organization","year":"2023"},{"key":"10.25259\/IJMR_1558_2025\/ref-2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/d41586-021-01696-3","article-title":"Delta coronavirus variant: Scientists brace for impact","volume":"595","author":"Callaway","year":"2021","journal-title":"Nature."},{"key":"10.25259\/IJMR_1558_2025\/ref-3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature."},{"key":"10.25259\/IJMR_1558_2025\/ref-4","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/s41467-023-38435-3","article-title":"Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants","volume":"14","author":"Tamura","year":"2023","journal-title":"Nat Commun"},{"key":"10.25259\/IJMR_1558_2025\/ref-5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature."},{"key":"10.25259\/IJMR_1558_2025\/ref-6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol."},{"key":"10.25259\/IJMR_1558_2025\/ref-7","volume-title":"Statement on classification of Omicron subvariant NB.1.8.1 as Variant Under Monitoring","author":"World Health Organization","year":"2025"},{"key":"10.25259\/IJMR_1558_2025\/ref-8","volume-title":"Data. WHO COVID-19 dashboard","author":"World Health Organization","year":"2025"},{"key":"10.25259\/IJMR_1558_2025\/ref-12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for delta (B.1.617.2) compared with Alpha (B.1.1.7)","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"10.25259\/IJMR_1558_2025\/ref-13","first-page":"133","article-title":"Laboratory surveillance for SARS-CoV-2 in India: Sequencing and variant monitoring","volume":"155","author":"Gupta","year":"2022","journal-title":"Indian J Med Res."},{"key":"10.25259\/IJMR_1558_2025\/ref-16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature."},{"key":"10.25259\/IJMR_1558_2025\/ref-17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(22)00365-6","article-title":"Neutralisation sensitivity of Omicron subvariants to therapeutic monoclonal antibodies","volume":"22","author":"Yamasoba","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"10.25259\/IJMR_1558_2025\/ref-18","volume-title":"Coronavirus pandemic (COVID-19)","author":"Our World in Data","year":"2025"},{"key":"10.25259\/IJMR_1558_2025\/ref-20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41591-023-02325-4","article-title":"Strengthening genomic surveillance for pandemic preparedness in India","volume":"29","author":"Bhattacharya","year":"2023","journal-title":"Nat Med."},{"key":"10.25259\/IJMR_1558_2025\/ref-21","first-page":"e009784","article-title":"Digital health and pandemic response in India: lessons from COVID-19","volume":"7","author":"Sharma","year":"2022","journal-title":"BMJ Glob Health."}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/emergence-of-sars-cov-2-omicron-subvariant-nb-1-8-1-in-india-genomic-evolution-transmission-patterns-and-public-health-implications\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/emergence-of-sars-cov-2-omicron-subvariant-nb-1-8-1-in-india-genomic-evolution-transmission-patterns-and-public-health-implications\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:16:59Z","timestamp":1773303419000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/emergence-of-sars-cov-2-omicron-subvariant-nb-1-8-1-in-india-genomic-evolution-transmission-patterns-and-public-health-implications\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":15,"alternative-id":["10.25259\/IJMR_1558_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_1558_2025","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"article-number":"104"}}